United States Hepatitis B Vaccines Market Report & Forecast 2021-2027

Publisher Name :
Date: 16-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Hepatitis B Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Hepatitis B Vaccines Market Segment Percentages, By Type, 2020 (%)

- Yeast Derived

- CHO Derived

United States Hepatitis B Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Hepatitis B Vaccines Market Segment Percentages, By Application, 2020 (%)

- Children

- Adult

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis B Vaccines revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Hepatitis B Vaccines revenues share in United States market, 2020 (%)

Key companies Hepatitis B Vaccines sales in United States market, 2016-2021 (Estimated), (M Doses)

Key companies Hepatitis B Vaccines sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- GSK

- NCPC

- Merck

- Bio Kangtai

- Dynavax

- Hissen

- KM Biologics

- LG Life Sciences

- Serum Institute

United States Hepatitis B Vaccines Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Hepatitis B Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Hepatitis B Vaccines Overall Market Size
2.1 United States Hepatitis B Vaccines Market Size: 2021 VS 2027
2.2 United States Hepatitis B Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Hepatitis B Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Hepatitis B Vaccines Players in United States Market
3.2 Top United States Hepatitis B Vaccines Companies Ranked by Revenue
3.3 United States Hepatitis B Vaccines Revenue by Companies
3.4 United States Hepatitis B Vaccines Sales by Companies
3.5 United States Hepatitis B Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis B Vaccines Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Hepatitis B Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Vaccines Players in United States Market
3.8.1 List of Tier 1 Hepatitis B Vaccines Companies in United States
3.8.2 List of Tier 2 and Tier 3 Hepatitis B Vaccines Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Hepatitis B Vaccines Market Size Markets, 2021 & 2027
4.1.2 Yeast Derived
4.1.3 CHO Derived
4.2 By Type - United States Hepatitis B Vaccines Revenue & Forecasts
4.2.1 By Type - United States Hepatitis B Vaccines Revenue, 2016-2021
4.2.2 By Type - United States Hepatitis B Vaccines Revenue, 2022-2027
4.2.3 By Type - United States Hepatitis B Vaccines Revenue Market Share, 2016-2027
4.3 By Type - United States Hepatitis B Vaccines Sales & Forecasts
4.3.1 By Type - United States Hepatitis B Vaccines Sales, 2016-2021
4.3.2 By Type - United States Hepatitis B Vaccines Sales, 2022-2027
4.3.3 By Type - United States Hepatitis B Vaccines Sales Market Share, 2016-2027
4.4 By Type - United States Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Hepatitis B Vaccines Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adult
5.2 By Application - United States Hepatitis B Vaccines Revenue & Forecasts
5.2.1 By Application - United States Hepatitis B Vaccines Revenue, 2016-2021
5.2.2 By Application - United States Hepatitis B Vaccines Revenue, 2022-2027
5.2.3 By Application - United States Hepatitis B Vaccines Revenue Market Share, 2016-2027
5.3 By Application - United States Hepatitis B Vaccines Sales & Forecasts
5.3.1 By Application - United States Hepatitis B Vaccines Sales, 2016-2021
5.3.2 By Application - United States Hepatitis B Vaccines Sales, 2022-2027
5.3.3 By Application - United States Hepatitis B Vaccines Sales Market Share, 2016-2027
5.4 By Application - United States Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK Hepatitis B Vaccines Product Description
6.1.5 GSK Recent Developments
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Overview
6.2.3 NCPC Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.2.4 NCPC Hepatitis B Vaccines Product Description
6.2.5 NCPC Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.3.4 Merck Hepatitis B Vaccines Product Description
6.3.5 Merck Recent Developments
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Overview
6.4.3 Bio Kangtai Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.4.4 Bio Kangtai Hepatitis B Vaccines Product Description
6.4.5 Bio Kangtai Recent Developments
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Overview
6.5.3 Dynavax Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.5.4 Dynavax Hepatitis B Vaccines Product Description
6.5.5 Dynavax Recent Developments
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Overview
6.6.3 Hissen Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.6.4 Hissen Hepatitis B Vaccines Product Description
6.6.5 Hissen Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Corporation Information
6.7.2 KM Biologics Overview
6.7.3 KM Biologics Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.7.4 KM Biologics Hepatitis B Vaccines Product Description
6.7.5 KM Biologics Recent Developments
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Overview
6.8.3 LG Life Sciences Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.8.4 LG Life Sciences Hepatitis B Vaccines Product Description
6.8.5 LG Life Sciences Recent Developments
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Overview
6.9.3 Serum Institute Hepatitis B Vaccines Sales and Revenue in United States Market (2016-2021)
6.9.4 Serum Institute Hepatitis B Vaccines Product Description
6.9.5 Serum Institute Recent Developments
7 United States Hepatitis B Vaccines Production Capacity, Analysis
7.1 United States Hepatitis B Vaccines Production Capacity, 2016-2027
7.2 Hepatitis B Vaccines Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Hepatitis B Vaccines Supply Chain Analysis
9.1 Hepatitis B Vaccines Industry Value Chain
9.2 Hepatitis B Vaccines Upstream Market
9.3 Hepatitis B Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Hepatitis B Vaccines Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Hepatitis B Vaccines in United States Market
Table 2. Top Hepatitis B Vaccines Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Hepatitis B Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Hepatitis B Vaccines Revenue Share by Companies, 2016-2021
Table 5. United States Hepatitis B Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. United States Hepatitis B Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis B Vaccines Price (2016-2021) & (USD/Doses)
Table 8. Manufacturers Hepatitis B Vaccines Product Type
Table 9. List of Tier 1 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Yeast Derived
Table 12. Major Manufacturers of CHO Derived
Table 13. By Type - United States Hepatitis B Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 17. By Type - United States Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 18. By Application - United States Hepatitis B Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 22. By Application - United States Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 26. GSK Hepatitis B Vaccines Product
Table 27. GSK Recent Developments
Table 28. NCPC Corporation Information
Table 29. NCPC Description and Major Businesses
Table 30. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 31. NCPC Hepatitis B Vaccines Product
Table 32. NCPC Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 36. Merck Hepatitis B Vaccines Product
Table 37. Merck Recent Developments
Table 38. Bio Kangtai Corporation Information
Table 39. Bio Kangtai Description and Major Businesses
Table 40. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 41. Bio Kangtai Hepatitis B Vaccines Product
Table 42. Bio Kangtai Recent Developments
Table 43. Dynavax Corporation Information
Table 44. Dynavax Description and Major Businesses
Table 45. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 46. Dynavax Hepatitis B Vaccines Product
Table 47. Dynavax Recent Developments
Table 48. Hissen Corporation Information
Table 49. Hissen Description and Major Businesses
Table 50. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 51. Hissen Hepatitis B Vaccines Product
Table 52. Hissen Recent Developments
Table 53. KM Biologics Corporation Information
Table 54. KM Biologics Description and Major Businesses
Table 55. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 56. KM Biologics Hepatitis B Vaccines Product
Table 57. KM Biologics Recent Developments
Table 58. LG Life Sciences Corporation Information
Table 59. LG Life Sciences Description and Major Businesses
Table 60. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 61. LG Life Sciences Hepatitis B Vaccines Product
Table 62. LG Life Sciences Recent Developments
Table 63. Serum Institute Corporation Information
Table 64. Serum Institute Description and Major Businesses
Table 65. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 66. Serum Institute Hepatitis B Vaccines Product
Table 67. Serum Institute Recent Developments
Table 68. Hepatitis B Vaccines Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 69. United States Hepatitis B Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Hepatitis B Vaccines Market Opportunities & Trends in United States Market
Table 71. Hepatitis B Vaccines Market Drivers in United States Market
Table 72. Hepatitis B Vaccines Market Restraints in United States Market
Table 73. Hepatitis B Vaccines Raw Materials
Table 74. Hepatitis B Vaccines Raw Materials Suppliers in United States Market
Table 75. Typical Hepatitis B Vaccines Downstream
Table 76. Hepatitis B Vaccines Downstream Clients in United States Market
Table 77. Hepatitis B Vaccines Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 2. Hepatitis B Vaccines Segment by Type
Figure 3. Hepatitis B Vaccines Segment by Application
Figure 4. United States Hepatitis B Vaccines Market Overview: 2020
Figure 5. United States Hepatitis B Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Hepatitis B Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis B Vaccines Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Vaccines Revenue in 2020
Figure 9. Yeast Derived Product Picture
Figure 10. CHO Derived Product Picture
Figure 11. By Type - United States Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 12. By Type - United States Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 13. By Type - United States Hepatitis B Vaccines Price (USD/Doses), 2016-2027
Figure 14. Children
Figure 15. Adult
Figure 16. By Application - United States Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 17. By Application - United States Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 18. By Application - United States Hepatitis B Vaccines Price (USD/Doses), 2016-2027
Figure 19. GSK Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. NCPC Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Merck Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Bio Kangtai Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Dynavax Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Hissen Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. KM Biologics Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. LG Life Sciences Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Serum Institute Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. United States Hepatitis B Vaccines Production Capacity (M Doses), 2016-2027
Figure 29. Hepatitis B Vaccines Industry Value Chain
Figure 30. Marketing Channels
  • Global and United States Urokinase Injection Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 138
    Urokinase Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Urokinase Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Urokinase......
  • Global and United States Urokinase Lyophilized Powder Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 135
    Urokinase Lyophilized Powder market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Urokinase Lyophilized Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuse......
  • Global and Japan Tablet and Capsule Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 149
    Tablet and Capsule Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tablet and Capsule Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on t......
  • Global and China Inhalation Powder Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 146
    Inhalation Powder Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation Powder Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the......
  • Global and United States Aerosols Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 148
    Aerosols Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Aerosols Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Aerosols ......
  • Global and United States Injectable Suspension Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 148
    Injectable Suspension Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Suspension Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this repor......
  • Global and China Buprenorphine Hydrochloride Tablets Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 145
    Buprenorphine Hydrochloride Tablets market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Buprenorphine Hydrochloride Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report ......
  • Global and China Buprenorphine Hydrochloride Injection Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 141
    Buprenorphine Hydrochloride Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Buprenorphine Hydrochloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this rep......
  • Global and United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 117
    Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Scope and Market Size Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Applicati......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs